2008
DOI: 10.1002/cbic.200800366
|View full text |Cite
|
Sign up to set email alerts
|

Chemical and Genetic Wrappers for Improved Phage and RNA Display

Abstract: An Achilles heel inherent to all molecular display formats, background binding between target and display system introduces false positives into screens and selections. For example, the negatively charged surfaces of phage, mRNA, and ribosome display systems bind with unacceptably high non-specificity to positively charged target molecules, which represent an estimated 35% of proteins in the human proteome. We report the first systematic attempt to understand why a broad class of molecular display selections f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
39
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 29 publications
(41 citation statements)
references
References 60 publications
2
39
0
Order By: Relevance
“…However, false positives may arise from retention of clones that bind non-specifically or from clones with genetic advantages for propagation that are not related to target binding (Brammer et al 2008). A recent report described an approach to address issues with non-specific charge interactions by genetically modifying phage coat proteins or using chemical agents to suppress non-specific interactions that occur between the negative charge on the phage coat surface with positively charged targets (Lamboy et al 2008). Phage clones recovered from library selections are then individually validated for target binding; yet, this is usually a time-consuming step that can strongly benefit from new methods to rapidly prioritize hits.…”
Section: Selections Against Purified Targets Intact Cells and Ex VImentioning
confidence: 99%
“…However, false positives may arise from retention of clones that bind non-specifically or from clones with genetic advantages for propagation that are not related to target binding (Brammer et al 2008). A recent report described an approach to address issues with non-specific charge interactions by genetically modifying phage coat proteins or using chemical agents to suppress non-specific interactions that occur between the negative charge on the phage coat surface with positively charged targets (Lamboy et al 2008). Phage clones recovered from library selections are then individually validated for target binding; yet, this is usually a time-consuming step that can strongly benefit from new methods to rapidly prioritize hits.…”
Section: Selections Against Purified Targets Intact Cells and Ex VImentioning
confidence: 99%
“…25 The viral capsid is aligned along the shaft and is composed of 2,700 copies of pVIII and ~5 copies of minor coat proteins pIII, pVI, pIX, and pVII located at either end. 21,22 The 50-residue pVIII (98% by mass) is composed of three distinct domains, namely, a negatively charged hydrophilic N-terminal domain (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20), an intermediate hydrophobic domain (21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39), and a positively charged domain (40)(41)(42)(43)(44)(45)(46)…”
Section: M13 Phagementioning
confidence: 99%
“…Lamboy et al 45 attempted to reduce nonspecific binding of positively charged proteins to the native negatively charged surface of phage for improved phage display system development. In order to neutralize the phage surface, the authors had either genetically engineered the phage to display charge-neutralizing peptides on the solvent-exposed surface or blocked the surface with oligolysine (eg, Lys8) against highly basic proteins in the proteome.…”
mentioning
confidence: 99%
“…The high negative charge on the phage surface allows non-covalent wrapping with cationic peptides and polymers. 29,30 Linking these wrappers to recognition ligands opens new routes to greater sensitivity and specificity for target analytes. The peptide ligands can be chemically synthesized and fused to an oligolysine peptide (K 14 ), which ‘wraps’ around the virus particle through complementary electrostatic interactions.…”
Section: Introductionmentioning
confidence: 99%